(Q71808002)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

5

K I Suh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

K U Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J Y Park

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

C H Kim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S K Hong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

K S Park

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S W Park

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1408-1414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Effect of long chain triglyceride infusion on glucose metabolism in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Interaction between glucose and free fatty acid metabolism in human skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Effect of fatty acids on glucose production and utilization in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Peripheral and hepatic insulin sensitivity in non-insulin-dependent diabetes mellitus: effect of nonesterified fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Acute changes in plasma non-esterified fatty acid concentration do not change hepatic glucose production in people with type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Insulin and glucose suppress hepatic glycogenolysis by distinct enzymatic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Enzymatic determination of serum-free fatty acids: a colorimetric method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Alanine and Gluconeogenesis in Man: Effect of Ethanol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Stimulation of gluconeogenesis by palmitic acid in rat hepatocytes: evidence that this effect can be dissociated from the provision of reducing equivalents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Control of hepatic glycogenolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Effect of nicotinic acid on plasma glucose concentration in normal individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Effects of insulin on glucagon-stimulated glucose production in the conscious dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

The fate of isotopic carbon in kidney cortex synthesizing glucose from lactate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990123-7

10.1016/S0026-0495(96)90123-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8931647%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference